133 results
Keyword Nitroderm TTS Remove keyword
-
List item
Referral: Fentanyl-ratiopharm_TTS
fentanyl, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/07/2007, EC decision date: 23/10/2007, Last updated: 14/12/2007Fentanyl-ratiopharm 25/50/75/100 μg/h TTS and associated names, is … Fentanyl-ratiopharm 25/50/75/100 μg/h TTS and associated names, transdermal … Fentanylratiopharm 25/50/75/100 μg/h TTS and associated names, that … -
List item
Human medicine European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
ChAdOx1-SARS-COV-2, COVID-19 virus infection
Date of authorisation: 29/01/2021,
, 
, Revision: 25, Authorised, Last updated: 30/11/2022
thrombocytopenia syndrome, TTS) and Guillain-Barré syndrome … thrombocytopenia syndrome (TTS) after receiving the vaccine … -
List item
EMA workshop on thrombosis with thrombocytopenia syndrome
Online, 27/06/2022, Last updated: 06/07/2022thrombocytopenia syndrome (TTS), an extremely rare but serious … studies of vaccine-induced TTS Session 2. Clinical characterisation … Clinical characterisation of TTS Session 3. Understanding … -
List item
News: EMA raises awareness of clinical care recommendations to manage suspected thrombosis with thrombocytopenia syndrome
Last updated: 07/06/2021thrombocytopenia syndrome (TTS) following vaccination with … and Haemostasis (ISTH). 2 TTS requires rapid identification … experience from managing TTS and heparin-induced thrombocytopenia … -
List item
Human medicine European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen) (updated)
adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S), COVID-19 virus infection
Date of authorisation: 11/03/2021,, , Revision: 27, Authorised, Last updated: 10/01/2023
blood platelets), known as TTS (thrombosis with thrombocytopenia … given to people who have had TTS following vaccination with … -
List item
News: Vaxzevria: further advice on blood clots and low blood platelets
CHMP, Last updated: 21/05/2021thrombocytopenia syndrome, TTS) after receiving the vaccine … thrombocytopenia syndrome (TTS) after previously receiving … receiving this vaccine. As TTS requires specialist treatment … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 September 2021
CHMP, Last updated: 17/09/2021thrombocytopenia syndrome, TTS) and on the use of a second … following the initial reports of TTS associated with the vaccine … data, including the latest TTS data from spontaneous reports … -
List item
National expert: Ralf Reinhard Tönjes, Paul Ehrlich Institute (updated)
- Declaration of interests - 80.25 KB | PDF
- Curriculum Vitae - 26.92 KB | PDF
-
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022
PRAC, Last updated: 14/01/2022thrombosis with thrombocytopenia (TTS) that occurred following … the majority of suspected TTS events were reported worldwide … people who have experienced TTS following vaccination with … -
List item
News: COVID-19 Vaccine Janssen: EMA recommendation on booster dose
CHMP, Last updated: 15/12/2021combination with thrombocytopenia (TTS) or other very rare side … -
List item
National expert: Inês Ribeiro-Vaz, National Authority of Medicines and Health Products, I.P. (updated)
- Declaration of interests - 79.85 KB | PDF
- Curriculum Vitae - 22.16 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen) (updated)
aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 30/06/2015,
, Revision: 15, Authorised, Last updated: 12/01/2023
-
List item
National expert: Ilko Getov, Bulgarian Drug Agency (updated)
- Declaration of interests - 80.09 KB | PDF
- Curriculum Vitae - 24.87 KB | PDF
cost (primer for fentanyl TTS in Bulgaria), Boll. Chim … -
List item
Human medicine European public assessment report (EPAR): Aripiprazole Zentiva
aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 25/06/2015,, Revision: 9, Authorised, Last updated: 26/08/2022
-
List item
Human medicine European public assessment report (EPAR): Aripiprazole Sandoz
aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 20/08/2015,, Revision: 9, Authorised, Last updated: 01/09/2022
-
List item
Human medicine European public assessment report (EPAR): Aripiprazole Accord
aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 15/11/2015,, Revision: 15, Authorised, Last updated: 13/07/2022
-
List item
Human medicine European public assessment report (EPAR): Nexavar
sorafenib, Carcinoma, Hepatocellular; Carcinoma, Renal Cell
Date of authorisation: 19/07/2006,
, Revision: 32, Authorised, Last updated: 06/12/2022
-
List item
Human medicine European public assessment report (EPAR): Nuvaxovid (updated)
SARS-CoV-2 recombinant spike protein, COVID-19 virus infection
Date of authorisation: 20/12/2021,, 
, Revision: 7, Authorised, Last updated: 10/01/2023
-
List item
Human medicine European public assessment report (EPAR): Abilify
aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 04/06/2004, Revision: 49, Authorised, Last updated: 08/04/2022 -
List item
Human medicine European public assessment report (EPAR): Xofigo
radium (223Ra) dichloride, Prostatic Neoplasms
Date of authorisation: 13/11/2013,, Revision: 12, Authorised, Last updated: 07/07/2022
-
List item
Human medicine European public assessment report (EPAR): Oprymea (updated)
pramipexole dihydrochloride monohydrate, Parkinson Disease
Date of authorisation: 12/09/2008,, Revision: 22, Authorised, Last updated: 17/01/2023
-
List item
Human medicine European public assessment report (EPAR): VidPrevtyn Beta
SARS-CoV-2 prefusion Spike delta TM protein, recombinant (B.1.351 strain), COVID-19 virus infection
Date of authorisation: 10/11/2022,, Authorised, Last updated: 30/11/2022
-
List item
Human medicine European public assessment report (EPAR): Sifrol
pramipexole dihydrochloride monohydrate, Restless Legs Syndrome; Parkinson Disease
Date of authorisation: 13/10/1997, Revision: 36, Authorised, Last updated: 12/08/2022 -
List item
Human medicine European public assessment report (EPAR): Mirapexin
pramipexole dihydrochloride monohydrate, Restless Legs Syndrome; Parkinson Disease
Date of authorisation: 23/02/1998, Revision: 39, Authorised, Last updated: 12/08/2022 -
List item
Human medicine European public assessment report (EPAR): Idelvion
albutrepenonacog alfa, Hemophilia B
Date of authorisation: 11/05/2016,, Revision: 10, Authorised, Last updated: 15/12/2021